CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 21,618 enrolled
Drug / intervention
Blood sampling +1 moreprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01190202
NCT01190202N/ACompleted

Epidemiology Study of Malaria Transmission Intensity in Sub-Saharan Africa

GlaxoSmithKline·interventional·Posted Aug 27, 2010·Updated Aug 18, 2020

In Brief

A clinical study evaluating Blood sampling and Assessment of body temperature for Malaria and Malaria Vaccines. Completed, enrolled 21,618 participants across 8 sites in 6 countries.

Detailed Summary

The aim of this epidemiology study is to characterize in a standardized way malaria transmission intensity at the clinical trial centers participating in study 110021 (NCT00866619).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesBurkina Faso, Gabon, Ghana, Kenya, Malawi, Tanzania

Timeline

N/ACompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedAug 27, 2010
Enrollment StartMar 14, 2011
Primary CompletionDec 20, 2013
TodayJul 2, 2026
Enrollment to primary: 2.8 yearsPosted 15.8 years ago

Interventions

Blood samplingprocedure

Capillary blood samples collected by finger/heel prick

Assessment of body temperatureprocedure

Assessment of axial body temperature with a digital thermometer